Recombinant CCN Domain Proteins and Fusion Proteins

Tue, 21 Apr 2026 13:30:11 +0000
Intellectual Property

USPTO granted Patent US12606602B2 to Oslo University Hospital HF covering recombinant proteins having CCN family thrombospondin type 1 repeat homology domains and fusion proteins combined with fusion partners and linker regions. The patent contains 18 claims and includes novel protease resistant Fc-fragments with applications in oncology.